Clinuvel says its share price weakness is typical of its peers. Meanwhile Opthea's trial timeline is on track and CMP ...
Vous n'êtes pas connecté
Kidney diseases house Proteomics International has parted ways with its US partner in favour of a ‘go-it-alone’ approach. ...
Clinuvel says its share price weakness is typical of its peers. Meanwhile Opthea's trial timeline is on track and CMP ...
Clinuvel says its share price weakness is typical of its peers. Meanwhile Opthea's trial timeline is on track and CMP ...
As China's influence grows across the Indo-Pacific, the United States has been doubling down on its alliances in the region to maintain a balance of...
As China's influence grows across the Indo-Pacific, the United States has been doubling down on its alliances in the region to maintain a balance of...
Diagnostics house Lumos has attracted Andrew "Twiggy" Forrest as a cornerstone investor amid a $10 million equity raise. ...
Diagnostics house Lumos has attracted Andrew "Twiggy" Forrest as a cornerstone investor amid a $10 million equity raise. ...
By Mohamed Chebaro Every time a newly elected UK leader sets off to see the American president of the day, the press in Britain and some in the US...
Proteomics International Laboratories has hired industry veteran Dr James Williams to help guide it towards commercialising its predictive diagnostics...
Proteomics International Laboratories has hired industry veteran Dr James Williams to help guide it towards commercialising its predictive diagnostics...
Love is in the air—or is it? New data from the Australian Bureau of Statistics (ABS) has given us a fresh look at the marriage and divorce trends in...